Assessment of Minimal Residual Disease (MRD) In Relapsed CLL Patients Treated with Fludarabine and Cyclophosphamide with or without Rituximab (REACH).

作者:Dufour Annika; Bohlander S K; Spiekermann Karsten; Schneider Stephanie; Braess Jan; Kakadiya Purvi; Mundt Kirsten E; Smith Helen; Lin Ming; Barrett Martin; Hurst Deborah; Dmoszynska Anna; Bence Bruckler Isabelle; Afanasiev Boris V; Catalano John; Montillo Marco; Geisler Christian H; Moiseev Sergey I; Solal Celigny Philippe; Robak Tadeusz; Hiddemann Wolfgang
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19